Program

 

23 August 2019

1:00 PMRegistration and Welcome coffee
2:00 PM

Welcome and opening
Jorge Santana, MD - University of Puerto Rico, Puerto Rico

Session 1: Keynote Lectures
Chairs: Charles Boucher & Jorge Santana
2:15 PM

Starting HAART in 2019: When and how
Pedro Cahn, MD, PhD - Fundación Huésped, Argentina

2:35 PM

Global challenges in hepatitis B treatment
Iván Antúnez-González, MD - Gastroenterology Society of Puerto Rico, Puerto Rico

2:55 PM 

Hepatitis C elimination: is it possible?
Andrea Cox, MD - Johns Hopkins School of Medicine, United States

3:15 PM Discussion
3:45 PM
Coffee Break
Session 2: HIV-related session
Chairs: Mauro Schechter & Carlos Rodríguez-Díaz
4:15 PM

Challenges with the implementation of PrEP
Kenneth Mayer, MD - The Fenway Institute/Harvard Medical School, United States

4:35 PM 

PrEP after sexual exposures
Mauro Schechter, MD, PhD - Federal University of Rio de Janeiro, Brazil

4:55 PM

New ARVs / New strategies
Pablo Tebas, MD - University of Pennsylvania, United States

5:15 PM Discussion
5:45 PMWelcome Reception & Poster Viewing
7:00 PMNetworking Dinner

24 August 2019

Session 3: Viral hepatitis-related
Chairs: Jorge Santana & Pedro Cahn
8:30 AM

Local situation in Puerto Rico (epidemiology & treatment options)
Jorge Santana, MD - University of Puerto Rico, Puerto Rico

9:00 AM

DDA's paradigm in HCV treatment
David Kershenobich Stalnikowitz, MD, Phd - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico

9:30 AM

Barriers in diagnosis and treatment of Hepatitis C
Federico Rodríguez-Pérez, MD - University of Puerto Rico, Puerto Rico

10:00 AMAbstract Presentation 1
10:15 AMDiscussion
10:45 AMCoffee Break & Poster Viewing
Session 4: ART in vulnerable populations
Chairs: Carlos Rodríguez-Díaz & Pablo Tebas
11:15 AMProblematic use of drugs and HIV and Hep risks in Puerto Rico (tbc)
Camila Gelpi-Acosta, PhD - LaGuardia Community College, USA
11:45 AMTreatment and care with vulnerable populations (tbc)
Amanda Castel, MD, MPH - George Washington University, USA
12:15 PMClinical case presentation(s)
Carlos Rodríguez-Díaz, PhD - George Washington University, USA
12:45 PMDiscussion 
1:00 PMLunch
Session 5: ART in special populations and Co-morbidities
Chairs: Chairs: Iván Antúnez-González & Pedro Cahn
1:45 PM

HCV treatment in renal impaired patients
David Roth, MD, PhD - University of Miami Health System, United States

2:15 PM

The struggles of the aging (co-infected) population
Iván Meléndez-Rivera, MD, FAAFP - Chief Medical Director - Centro Ararat, Inc

2:45 PM

HepC issues in liver transplantation
José Rivera-Acosta, MD - Hospital Auxilio Mútuo, Puerto Rico

3:15 PMAbstract Presentation 2
3:30 PMDiscussion
3:45 PMCoffee Break
Session 6: Future challenges
Chairs: Jorge Santana & Mauro Schechter
4:15 PM 

From long-acting antivirals to functional cure
Pablo Tebas, MD - University of Pennsylvania, United States

4:45 PM

HIV and viral hepatitis: Cascade of care in Puerto Rico
Angeles Rodríguez, MD, MPH - Department of Health, Puerto Rico

5:15 PM Round Table Discussion: Cascade of care
5:45 PM 

Closing Remarks
Jorge Santana, MD - University of Puerto Rico, Puerto Rico